A Phase 3, Randomized, Global Trial of Nivolumab and Epacadostat With Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in First-line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Epacadostat (Primary) ; Carboplatin; Cisplatin; Gemcitabine; Nivolumab; Paclitaxel; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Sponsors Incyte Corporation
- 31 Jan 2018 Status changed from not yet recruiting to recruiting.
- 16 Nov 2017 Status changed from planning to not yet recruiting.
- 04 May 2017 According to an Incyte Corporation media release, this trial is expected to initiate in 2017.